203 related articles for article (PubMed ID: 32150265)
1. High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis.
Xue E; Xie H; Leisenring WM; Kimball LE; Goyal S; Chung L; Blazevic R; Maltez B; Edwards A; Dahlberg AE; Salit RB; Delaney C; Pergam SA; Boeckh M; Milano F; Hill JA
Clin Infect Dis; 2021 Apr; 72(8):1350-1357. PubMed ID: 32150265
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation.
Fukushi K; Konuma T; Monna-Oiwa M; Isobe M; Kato S; Kuroda S; Takahashi S; Nannya Y
Transplant Cell Ther; 2022 Jun; 28(6):339.e1-339.e7. PubMed ID: 35364334
[TBL] [Abstract][Full Text] [Related]
3. Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies.
Sahoo F; Hill JA; Xie H; Leisenring W; Yi J; Goyal S; Kimball LE; Lee I; Seo S; Davis C; Pergam SA; Flowers ME; Liaw KL; Holmberg L; Boeckh M
Biol Blood Marrow Transplant; 2017 Mar; 23(3):505-511. PubMed ID: 28039754
[TBL] [Abstract][Full Text] [Related]
4. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.
Su SH; Martel-Laferrière V; Labbé AC; Snydman DR; Kent D; Laverdière M; Béliveau C; Logvinenko T; Cohen S; Lachance S; Kiss T; Roy J
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1012-7. PubMed ID: 20977944
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant.
Mao J; McPheeters JT; Zhang D; Acosta CJ; Finelli L
Curr Med Res Opin; 2018 Apr; 34(4):741-749. PubMed ID: 28945107
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.
Pavlopoulou ID; Poulopoulou S; Melexopoulou C; Papazaharia I; Zavos G; Boletis IN
BMC Infect Dis; 2015 Jul; 15():285. PubMed ID: 26204926
[TBL] [Abstract][Full Text] [Related]
7. Varicella Zoster Virus Infection in Children with Autologous Hematopoietic Cell Transplantation: A Retrospective, Single-Center Study in Korea.
Kang JM; Kim JM; Lee JW; Yoo KH; Sung KW; Koo HH; Kim YJ
Biol Blood Marrow Transplant; 2020 May; 26(5):965-971. PubMed ID: 31962166
[TBL] [Abstract][Full Text] [Related]
8. Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Seo HM; Kim YS; Bang CH; Lee JH; Lee JY; Lee DG; Park YM
Antiviral Res; 2017 Apr; 140():106-115. PubMed ID: 28132866
[TBL] [Abstract][Full Text] [Related]
9. A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuation.
Feng CJ; Zhao P; Fu HX; Yan CH; Wang CC; Zhu XL; He Y; Wang FR; Zhang YY; Mo XD; Kong Y; Han W; Wang JZ; Wang Y; Chen H; Chen YH; Zhao XY; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Am J Hematol; 2024 Apr; 99(4):633-641. PubMed ID: 37772366
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for herpes zoster following heart transplantation.
Koo S; Gagne LS; Lee P; Pratibhu PP; James LM; Givertz MM; Marty FM
Transpl Infect Dis; 2014 Feb; 16(1):17-25. PubMed ID: 24147978
[TBL] [Abstract][Full Text] [Related]
11. Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis.
Baumrin E; Cheng MP; Kanjilal S; Ho VT; Issa NC; Baden LR
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1642-1647. PubMed ID: 31004745
[TBL] [Abstract][Full Text] [Related]
12. Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational Study.
Zhang D; Weiss T; Feng Y; Finelli L
Adv Ther; 2017 Jul; 34(7):1610-1621. PubMed ID: 28508307
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study.
Han SB; Kim SK; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH
Medicine (Baltimore); 2017 Apr; 96(14):e6546. PubMed ID: 28383421
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
Wada-Shimosato Y; Tanoshima R; Hiratoko K; Takeuchi M; Tsujimoto SI; Shiba N; Ito S; Yamanaka T; Ito S
Transpl Infect Dis; 2019 Jun; 21(3):e13061. PubMed ID: 30756465
[TBL] [Abstract][Full Text] [Related]
15. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.
Erard V; Guthrie KA; Varley C; Heugel J; Wald A; Flowers ME; Corey L; Boeckh M
Blood; 2007 Oct; 110(8):3071-7. PubMed ID: 17515400
[TBL] [Abstract][Full Text] [Related]
16. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation.
Ko GB; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Kim YH; Park JB; Lee SK; Park SK; Park JS; Han DJ; Lee SO
Transpl Infect Dis; 2013 Aug; 15(4):416-23. PubMed ID: 23676124
[TBL] [Abstract][Full Text] [Related]
18. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ; Mullane KM; Cornely OA; Boeckh MJ; Brown JW; Pergam SA; Trociukas I; Žák P; Craig MD; Papanicolaou GA; Velez JD; Panse J; Hurtado K; Fernsler DA; Stek JE; Pang L; Su SC; Zhao Y; Chan ISF; Kaplan SS; Parrino J; Lee I; Popmihajlov Z; Annunziato PW; Arvin A;
Lancet; 2018 May; 391(10135):2116-2127. PubMed ID: 29856344
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
[TBL] [Abstract][Full Text] [Related]
20. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.
Pollack M; Heugel J; Xie H; Leisenring W; Storek J; Young JA; Kukreja M; Gress R; Tomblyn M; Boeckh M
Biol Blood Marrow Transplant; 2011 May; 17(5):664-73. PubMed ID: 20699126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
